BRCA1 expression, its correlation with clinicopathological features, and response to neoadjuvant chemotherapy in high-grade serous ovarian cancer.

Akkamahadevi PatilSharada PatilC E AnupamaSavitha RajarajanVidya P NimbalkarUsha AmirthamG ChampakaM N SumaGeetha V PatilAshwini NargundV R PallaviLinu JacobC S PremalathaJyothi S Prabhu

Published in: The journal of obstetrics and gynaecology research (2023)

Our findings show the utility of the BRCA1/ID4 ratio in predicting neoadjuvant therapy response, which needs further evaluation in larger cohorts with long-term outcomes.

Keyphrases

high grade
neoadjuvant chemotherapy
locally advanced
lymph node
rectal cancer
low grade
poor prognosis
sentinel lymph node
squamous cell carcinoma
breast cancer risk
radiation therapy
binding protein
early stage
long non coding rna
cell therapy
smoking cessation